November 3, 2019
UPCOMING FALL GROUP MEETING CONVENES NOVEMBER 7-9
The Alliance for Clinical Trials in Oncology will convene its 2019 Fall Group Meeting in Chicago November 7-9. Scientists, clinical research professionals, patient advocates and others interested in the latest developments in cancer research are expected to attend the three-day meeting at the
October 15, 2019
Alliance A071801: Phase III trial of post-surgical single fraction stereotactic radiosurgery (SRS) compared with fractionated SRS (FSRS) for resected metastatic brain disease Overview: Alliance investigator Paul Brown, MD, of Mayo Clinic, leads this phase III trial to see how well single fraction stereotactic radiosurgery works compared with fractionated stereotactic radiosurgery in treating patients with cance
October 1, 2019
Alliance A021703: Randomized double-blind phase III trial of vitamin D3 supplementation in patients with previously untreated metastatic colorectal cancer (SOLARIS) Overview: Alliance investigator Kimmie Ng, MD, of Dana-Farber Cancer Institute, leads this phase III trial that looks at how well vitamin D3 given with standard chemotherapy and bevacizumab works in treating patients with colorectal cancer that h
